Literature DB >> 14558603

Harvesting blood stem cells from cranial bone at craniotomy--a preliminary study.

Tomomi Iwashita1, Tsuyoshi Tada, Hua Zhan, Yuichiro Tanaka, Kazuhiro Hongo.   

Abstract

Primary brain tumors seldom infiltrate into the cranium, even if they are invasive in the central nervous system. In this study, we examined whether blood stem cells can be harvested from cranial bone at craniotomy. Bone marrow cells in cranial bone were counted in 181 craniotomy specimens after staining with hematoxylin and eosin. Marrow volume was measured in 37 specimens using three-dimensional computed tomography (CT). In 10 cases, viable cells collected from very small bone pieces at craniotomy were cultured to examine granulocyte/macrophage colony-forming units (CFU-GM). In 2 cases, bone marrow cells were practically harvested from removed bone at surgery. The weight of bone flap at craniotomy was 35.0 +/- 18.0 g. Bone flap marrow contained 1.5 x 10(9) cells/ml. CT examination showed that bone flap volume was 35.0 +/- 9.0 ml and marrow ratio was 65.1 +/- 13.5%. Thus, at craniotomy, a typical bone flap contained about 3.4 x 10(10) cells. Bone marrow cell count gradually decreased as subject age increased. The bone pieces obtained at craniotomy contained 3.1 +/- 3.4 x 10(6) cells/g, and CFU-GM count was 0.4 x 10(5) cells/g. In one case, we collected 3.4 x 10(8) cells, including 1.8 x 10(6) CFU-GM colonies. In another case, we collected 9.7 x 10(8) cells, including 4.8 x 10(6) CFU-GM colonies. These findings indicate that, at craniotomy, the number of blood stem cells in a typical bone flap is sufficient for autologous blood stem cell rescue.

Entities:  

Mesh:

Year:  2003        PMID: 14558603     DOI: 10.1023/a:1025684903137

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  24 in total

Review 1.  An update from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry on current activity in hematopoietic stem cell transplantation.

Authors:  M M Horowitz; P A Rowlings
Journal:  Curr Opin Hematol       Date:  1997-11       Impact factor: 3.284

2.  Importance of marrow dose on posttransplant outcome in acute leukemia: models derived from patients autografted with mafosfamide-purged marrow at a single institution.

Authors:  N C Gorin; M Labopin; J P Laporte; L Douay; M Lopez; S Lesage; L Fouillard; F Isnard; J P Jouet; N Bellal; C Perot; J Van Den Akker; F Bauters; A Najman
Journal:  Exp Hematol       Date:  1999-12       Impact factor: 3.084

3.  Treatment of intracranial nongerminomatous germ-cell tumor by high-dose chemotherapy and autologous stem-cell rescue.

Authors:  T Tada; T Takizawa; F Nakazato; S Kobayashi; K Koike; M Oguchi; E Ishii; Y Amano
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

4.  Major complications of marrow harvesting for transplantation.

Authors:  M M Bortin; C D Buckner
Journal:  Exp Hematol       Date:  1983-11       Impact factor: 3.084

Review 5.  Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study.

Authors:  E H Kovnar; S J Kellie; M E Horowitz; R A Sanford; J W Langston; R K Mulhern; J J Jenkins; E C Douglass; E E Etcubanas; D L Fairclough
Journal:  J Clin Oncol       Date:  1990-02       Impact factor: 44.544

6.  Isolation of putative progenitor endothelial cells for angiogenesis.

Authors:  T Asahara; T Murohara; A Sullivan; M Silver; R van der Zee; T Li; B Witzenbichler; G Schatteman; J M Isner
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

7.  Combination chemotherapy with high-dose methotrexate and cytarabine with or without brain irradiation for primary central nervous system lymphomas.

Authors:  Antonello Calderoni; Stefan Aebi
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

8.  Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer.

Authors:  A D Elias; L Ayash; K C Anderson; M Hunt; C Wheeler; G Schwartz; I Tepler; R Mazanet; C Lynch; S Pap
Journal:  Blood       Date:  1992-06-01       Impact factor: 22.113

9.  A special report: bone marrow transplants using volunteer donors--recommendations and requirements for a standardized practice throughout the world--1994 update. The WMDA Executive Committee.

Authors:  J M Goldman
Journal:  Blood       Date:  1994-11-01       Impact factor: 22.113

10.  Bone marrow mononuclear cell count does not predict neutrophil and platelet recovery following autologous bone marrow transplant: value of the colony-forming unit granulocyte-macrophage (CFU-GM) assay.

Authors:  F al-Fiar; H M Prince; K Imrie; A K Stewart; M Crump; A Keating
Journal:  Cell Transplant       Date:  1997 Sep-Oct       Impact factor: 4.139

View more
  5 in total

1.  Photobiomodulation and the brain: a new paradigm.

Authors:  Madison Hennessy; Michael R Hamblin
Journal:  J Opt       Date:  2016-12-14       Impact factor: 2.516

Review 2.  Photobiomodulation for traumatic brain injury and stroke.

Authors:  Michael R Hamblin
Journal:  J Neurosci Res       Date:  2017-11-13       Impact factor: 4.164

Review 3.  Shining light on the head: Photobiomodulation for brain disorders.

Authors:  Michael R Hamblin
Journal:  BBA Clin       Date:  2016-10-01

4.  Correlation of plasma FL expression with bone marrow irradiation dose.

Authors:  Mary Sproull; Dane Avondoglio; Tamalee Kramp; Uma Shankavaram; Kevin Camphausen
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

5.  Role of a Burr Hole and Calvarial Bone Marrow-Derived Stem Cells in the Ischemic Rat Brain: A Possible Mechanism for the Efficacy of Multiple Burr Hole Surgery in Moyamoya Disease.

Authors:  Taek-Kyun Nam; Seung-Won Park; Yong-Sook Park; Jeong-Taik Kwon; Byung-Kook Min; Sung-Nam Hwang
Journal:  J Korean Neurosurg Soc       Date:  2015-09-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.